Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.,The New England Journal of Medicine - X-MOL

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2020-06-04 , DOI: 10.1056/nejmoa1915315
Véronique Minard-Colin ₁ , Anne Aupérin ₁ , Marta Pillon ₁ , G A Amos Burke ₁ , Donald A Barkauskas ₁ , Keith Wheatley ₁ , Rafael F Delgado ₁ , Sarah Alexander ₁ , Anne Uyttebroeck ₁ , Catherine M Bollard ₁ , József Zsiros ₁ , Monika Csoka ₁ , Bernarda Kazanowska ₁ , Alan K Chiang ₁ , Rodney R Miles ₁ , Andrew Wotherspoon ₁ , Peter C Adamson ₁ , Gilles Vassal ₁ , Catherine Patte ₁ , Thomas G Gross ₁ , ,

Affiliation

From the Departments of Pediatric and Adolescent Oncology (V.M.-C., C.P.) and Clinical Research (G.V.), INSERM Unité 1015 (V.M.-C.), and the Unit of Biostatistics and Epidemiology and INSERM Unité 1018 (A.A.), Gustave Roussy, Université Paris-Saclay, Villejuif, France; the Department of Pediatric Hematology and Oncology, University of Padua, Padua, Italy (M.P.); the Department of Paediatric Haematology, Oncology, and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge (G.A.A.B.), Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham (K.W.), and the Department of Histopathology, Royal Marsden NHS Foundation Trust, London (A.W.) - all in the United Kingdom; the Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles (D.A.B.); the Department of Pediatric Hematology and Oncology, University of Valencia, Valencia, Spain (R.F.D.); the Division of Haematology-Oncology, Hospital for Sick Children, Toronto (S.A.); the Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium (A.U.); the Center for Cancer and Immunology Research, Children's National Health System and George Washington University, Washington, DC (C.M.B.); Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands (J.Z.); the Department of Pediatric Hematology and Oncology, Semmelweis University, Budapest, Hungary (M.C.); the Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland (B.K.); the Department of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong (A.K.C.); the Department of Pathology, University of Utah, Salt Lake City (R.R.M.); Children's Hospital of Philadelphia, Philadelphia (P.C.A.); and the National Cancer Institute, Center for Global Health, Rockville, MD (T.G.G.).

New England Journal of Medicine, Volume 382, Issue 23, Page 2207-2219, June 2020.

中文翻译：

利妥昔单抗用于治疗儿童高风险、成熟 B 细胞非霍奇金淋巴瘤。

《新英格兰医学杂志》，第 382 卷，第 23 期，第 2207-2219 页，2020 年 6 月。

更新日期：2020-06-04

点击分享查看原文

点击收藏

阅读更多本刊最新论文

相关文章参考文献引文

点击加载相关文章

全部期刊列表>>

阿拉丁

英语语言编辑翻译加编辑

专注于基础生命科学与临床研究的交叉领域

遥感数据采集

数字地球

开学添书香，满额有好礼

加速出版服务

编辑润色服务全线九折优惠

传播分子、细胞和发育生物学领域的重大发现

环境管理资源效率浪费最小化

先进材料生物材料

聚焦分子细胞和生物体生物学

“转化老年科学”.正在征稿

化学工程

wiley你是哪种学术人格

细胞生物学

100+材料学期刊

人工智能新刊

图书出版流程

征集眼内治疗给药新技术

英语语言编辑服务

快速找到合适的投稿机会

动态系统的数学与计算机建模

热点论文一站获取

定位全球科研英才

中国图象图形学学会合作刊

东北石油大学合作期刊

动物源性食品遗传学与育种

专业英语编辑服务

中科大

华盛顿

上海交大

中山大学

西湖大学

药物所

普渡大学

东方理工

ACS材料视界

客服邮箱：service@x-mol.com
官方微信：X-molTeam2
邮编：100098
地址：北京市海淀区知春路56号中航科技大厦

bug